Recent studies revealed that Cyclopamine not only reduces cell viability but also enhances temozolomide (TMZ) efficacy by inducing apoptosis through cleaved caspase-3 activation, along with upregulating stemness markers like SOX-2 and OCT-4 in GBM cells [135]. Here, SOX2 is linked to glioblastoma.